Rear-mounted aerodynamic structures for cargo bodies

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Stemco Lp patent solves the following problem:

Trucking is the primary means of long-distance and short-haul transportation of goods and materials in the United States, and in many other countries. Trucks often include a motorized cab where the driver sits and working on cars. cab attached to a box-like cargo section. Smaller trucks often include an integrated cargo section sitting in a unified framework which extends from the front wheels to the rear wheel assembly. The larger trucks often includes a detachable cab unit, with many driven axles, and a special trailer with a long box-like cargo units served on two or more phrases assemblies wheels. These trucks assemblages commonly called semi-trailers or tractor trailers. Most modern trucks' cabs, especially for tractor trailers, fitted with aerodynamic fairings on the roof, side and front. These fairings to help direct air over the exposed surface of the box-like cargo body, generally gave higher (a few feet) than the average roof cab. The flat, projecting front face of a cargo body is a strong source of drag on the cab roof. The use of the front-mounted aerodynamic fairings in recent years have served to significantly lower drag and, therefore, raise fuel economy for trucks, especially those traveling at high speed in the open roads.

Our analysis of this patent is as follows:

Stemco Lp’s patent US 9457847 B2 deals with Rear-mounted aerodynamic structures for cargo bodies.
A rear-mounted aerodynamic framework for taking a cargo body includes a three or four-sided structure with a deployed position to help improve flight efficiency in cargo body. The cargo body may be the body of a trailer of a tractor-trailer vehicle or trailer towed behind a vehicle like a truck. It consists of a trailer body or other body cargo well-known in the art. A destroyer run guard mounted on a top surface of the rear cargo body, as additional aerodynamic structures or as a standalone destroyer for cargo bodies. The three or four-sided rear-mounted aerodynamic structure can contain any of a variety of illustrative embodiments shown and described herein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nutritional composition with probiotics

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The N.V. Nutricia patent solves the following problem:

Infants without intestinal flora at birth. As a result of contact with the mother during birth and subsequent feeding with human milk or formula milk, the intestinal flora rapidly. During the development, the intestinal flora is still immature and normal activities are weak. Human milk-fed infants are less afflicted by infections or diseases than formula-fed infants. Thus, human milk-fed children have less gastro-intestinal infections in terms of incidents and the duration, less atopic diseases such as allergies, eczema, less colics and cramps, and less constipation than formula-fed infants. pain came later in life, such as childhood obesity, diabetes, and asthma are related to the kind of feeding during the early stages of life, with human milk-fed infants for good .

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 9314047 B2 deals with Nutritional composition with probiotics.
A composition comprising Bifidobacterium breve, a non-digestible saccharide A and a non-digestible saccharide B, optionally with Lactobacillus paracasei and the use of said composition for the treatment and / or prevention of gastro-intestinal disorders, immune disorder and / or endocrine disorder.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Flame retardant polymer compositions

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Sabic Global Technologies B.V. patent solves the following problem:

Crosslinked polyamide compositions known in the art (See, W. Feng et al., Radiation Physics and Chemistry, 63, pp. 493-496 (2002)). Japanese published application 59-012936A2 describes a crosslinked polyamide resins that obtained by exposing a polyamide resin containing a crosslinker of a radiation beam. resin will be free glass fiber, and a flame retardant or filler can be incorporated into the resin.

Our analysis of this patent is as follows:

Sabic Global Technologies B.V.’s patent US 9006306 B2 deals with Flame retardant polymer compositions.
On the one hand, the invention relates to cross-linking, the flame retardant polymer composition which comprises a polyamide or polyester; a flame retardant system; a crosslinking agent; and a flame retardant coagent system. abstract It is intended as a scanning tool for purposes of searching in the particular art and is not intended to limit the present invention.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Compounds

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Glaxo Group Limited patent solves the following problem:

Syk is a non-receptor tyrosine kinase involved in coupling activated immunoreceptors signal consuming events that mediate diverse cellular responses, including proliferation, distinction, and phagocytosis. Syk is widely expressed in hematopoietic cells. Syk inhibitor with potential anti-inflammatory and immunomodulating activities. They inhibit SYK-mediated IgG Fc epsilon and gamma receptor and BCR receptor signaling, resulting in inhibition of activation of mast cells, macrophages, and B-cells and relevant inflammatory responses and tissue damage. Mast cells play a major role in type I hypersensitivity reactions associated with urticaria, bronchial asthma, anaphylaxis and other allergic conditions. Therefore, SYK inhibitor has attracted interest from a number of therapeutic areas, including the treatment of rheumatoid arthritis, B-cell lymphoma, asthma, rhinitis and cutaneous disorders such as acute and chronic urticaria, mastocytosis, cutaneous lupus , atopic dermatitis, autoimmune bullous conditions including Pemphigus and pemphigoid and other mast cell mediated skin disease.

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8993560 B2 deals with Compounds.
A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potential use in the treatment of diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for example inflammatory diseases and / or allergic conditions, in cancer therapy, especially heme malignancies, and autoimmune conditions.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 8987456 B2 deals with 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain 3-pyridyl formamide-containing compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nasal administration

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Optinose As patent solves the following problem:

Our analysis of this patent is as follows:

Optinose As’s patent US 8875704 B2 deals with Nasal administration.
A delivery device and method to deliver a powdered substance, in particular a triptan, such as sumatriptan, the anal region of a nasal cavity of a subject, in particular for the treatment of headache head, for example, cluster headaches and migraine, and neuropathic pain, the delivery device comprising: a nosepiece for insertion into a nasal cavity of a subject with which the powdered substance delivered to the posterior region of the nasal cavity of the subject, in particular on the bottom two thirds of the nasal cavity; and a substance supply unit that is operable to deliver the powdered substance through the nosepiece.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The N.V. Nutricia patent solves the following problem:

Age-related volunteers loss of muscle mass and strength occurs during the ages and is called sarcopenia [1]. As the degenerative loss of skeletal muscle mass, it occurs at a rate of 3-8% per decade after the age of 30 years, and accelerate from 60 years of age. The two impaired muscle mass and muscle strength associated with age-related loss of muscle function.

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 8846759 B2 deals with Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis.
The present invention relates to the use of a low-caloric high-protein nutritional composition for use in the prevention or treatment of a disease or condition in a mammal, including muscle decline, as well as specific low-caloric high-protein nutritional composition for stimulating muscle protein synthesis in a mammal. In particular, the invention relates to the use of a nutritional composition comprising per 100 kcal: (i) at least 12 g of proteinaceous matter comprising at least about 80 weight% of whey protein, relative to total proteinaceous matter, and containing at least 11 weight% of leucine, relative to the total proteinaceous matter, at least 20 weight% in a free form, relative to the total leucine, ( ii) a source of fat and a source of digestible carbohydrates, for the prevention or treatment of a disease or condition involving reduced muscle in a mammal, especially in an old mammal, which nutritional composition administered as 1 to 2 servings daily, each serving consisting of between 80 and 200 kcal.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Preventing diseases in infants delivered via caesarean section

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The N.V. Nutricia patent solves the following problem:

Human milk contains non-digestible oligosaccharides which specifically stimulate the growth of lactic acid bacteria, such as species belonging to the genus Bifidobacterium and Lactobacillus and prevent the growth and / or adhesion to the intestinal wall of other ( pathogenic) bacteria. Therefore, when a child receives human milk, intestinal flora in infants into a healthy plant rich in lactic acid bacteria. The presence of a healthy intestinal flora improves gut barrier maturation and / or gut barrier integrity, stimulates make mucus, inhibits pathogenic bacteria and stimulates the immune system.

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 8715769 B2 deals with Preventing diseases in infants delivered via caesarean section.
The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration of a baby delivered by caesarean section.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Undercarriage fairing

File for Quick & Easy Patent Protection with PowerPatent.

The Aerodynamic Trailer Systems, Llc patent solves the following problem:

The present invention claims priority to US provisional Use Ser. No. 61 / 244,929 and Aug. 23, 2009 incorporated here by reference.

Our analysis of this patent is as follows:

Aerodynamic Trailer Systems, Llc’s patent US 8276972 B2 deals with Undercarriage fairing.
The present disclosure provides an Airstream deflector fairing consisting of a front end with a first edge attached to an undercarriage of a car wheel. The fairing further includes a rear or aft end and a lower lower fairing includes a panel facing the ground at an angle, which in turn directs an Airstream throw THEREUNDER downwardly and without relatives in the undercarriage and the greatest somewhere beneath a trailing axle under the fairing. The lower bottom panel includes a declination angle relative to the undercarriage from 12 degrees to 24 degrees.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for producing hydroxylammonium salts

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Domo Caproleuna Gmbh patent solves the following problem:

The invention relates to a method of making hydroxylammonium salts in catalytic reduction of nitrogen monoxide with hydrogen in a diluted aqueous solution of mineral acid in the presence of platinum catalysts suspended in a support in many subsequent reaction round .

Our analysis of this patent is as follows:

Domo Caproleuna Gmbh’s patent US 7608236 B2 deals with Method for producing hydroxylammonium salts.
One way to make hydroxylammonium salts in catalytic reaction of nitrogen monoxide with hydrogen in a diluted aqueous solution of mineral acid in the presence of platinum catalysts suspended in a support in many subsequent reaction stages. This reaction occurs in a stirred reactor in which a gas inlet and distribution system is given at the bottom of the stirred reactor, a disk misleading placed immediately upon the birth center or face support and more angled, concave and tilted misleading blades that rotate their angled or concave sides in the direction of movement, and a two-edged misleading given the misleading shaft in the upper part of the stirred reactor, the individual leaves offset like lamellas that they always wet the reactor cap when rotating.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.